Ximelagatran-an oral direct thrombin inhibitor.
Tong
Lisa M
LM
University of California, San Francisco, School of Pharmacy, Box 0622, 521 Parnassus Avenue, Room C-152, San Francisco, CA 94143-0622, USA. lmtong@itsa.ucsf.edu.
D000925:Anticoagulants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001384:Azetidines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001596:Benzylamines; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D019637:Orthopedic Procedures; D011183:Postoperative Complications / Q000517:prevention & control; D020521:Stroke / Q000517:prevention & control; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran